A preclinical mouse model of invasive lobular breast cancer metastasis
CW Doornebal, S Klarenbeek, TM Braumuller, CN Klijn… - Cancer research, 2013 - AACR
Metastatic disease accounts for more than 90% of cancer-related deaths, but the
development of effective antimetastatic agents has been hampered by the paucity of …
development of effective antimetastatic agents has been hampered by the paucity of …
[PDF][PDF] A preclinical mouse model of invasive lobular breast cancer metastasis
CW Doornebal, S Klarenbeek, TM Braumuller, CN Klijn… - scholar.archive.org
Metastatic disease accounts for over 90% of cancer-related deaths, but the development of
effective anti-metastatic agents has been hampered by the paucity of clinically relevant …
effective anti-metastatic agents has been hampered by the paucity of clinically relevant …
[引用][C] A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
CW DOORNEBAL, S KLARENBEEK… - Cancer research …, 2013 - pascal-francis.inist.fr
A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
[PDF][PDF] A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
CW Doornebal, S Klarenbeek, TM Braumuller, CN Klijn… - academia.edu
Metastatic disease accounts for more than 90% of cancer-related deaths, but the
development of effective antimetastatic agents has been hampered by the paucity of …
development of effective antimetastatic agents has been hampered by the paucity of …
A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
CW Doornebal, S Klarenbeek, TM Braumuller… - Cancer …, 2013 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Metastatic disease accounts for more than
90% of cancer-related deaths, but the development of effective antimetastatic agents has …
90% of cancer-related deaths, but the development of effective antimetastatic agents has …
[PDF][PDF] A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
CW Doornebal, S Klarenbeek, TM Braumuller, CN Klijn… - researchgate.net
Metastatic disease accounts for more than 90% of cancer-related deaths, but the
development of effective antimetastatic agents has been hampered by the paucity of …
development of effective antimetastatic agents has been hampered by the paucity of …
A preclinical mouse model of invasive lobular breast cancer metastasis.
CW Doornebal, S Klarenbeek, TM Braumuller… - Cancer …, 2012 - europepmc.org
Metastatic disease accounts for more than 90% of cancer-related deaths, but the
development of effective antimetastatic agents has been hampered by the paucity of …
development of effective antimetastatic agents has been hampered by the paucity of …
A preclinical mouse model of invasive lobular breast cancer metastasis
CW Doornebal, S Klarenbeek… - Cancer …, 2013 - pubmed.ncbi.nlm.nih.gov
Metastatic disease accounts for more than 90% of cancer-related deaths, but the
development of effective antimetastatic agents has been hampered by the paucity of …
development of effective antimetastatic agents has been hampered by the paucity of …